FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation

被引:124
作者
Meloni, I
Muscettola, M
Raynaud, M
Longo, I
Bruttini, M
Moizard, MP
Gomot, M
Chelly, J
des Portes, V
Fryns, JP
Ropers, HH
Magi, B
Bellan, C
Volpi, N
Yntema, HG
Lewis, SE
Schaffer, JE
Renieri, A [1 ]
机构
[1] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy
[2] INSERM, U316, Serv Genet, Tours, France
[3] CHU Cochin, ICGM, INSERM, U129, Paris, France
[4] Katholieke Univ Leuven, Dept Genet, Louvain, Belgium
[5] Max Planck Inst Mol Genet, Berlin, Germany
[6] Univ Siena, Dept Pathol, I-53100 Siena, Italy
[7] Univ Siena, Dept Biomed Sci, I-53100 Siena, Italy
[8] Dept Human Genet, Nijmegen, Netherlands
[9] Washington Univ, Dept Internal Med, St Louis, MO USA
[10] Washington Univ, Dept Mol Biol, St Louis, MO USA
[11] Washington Univ, Dept Pharmacol, St Louis, MO USA
关键词
D O I
10.1038/ng857
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
X-linked mental retardation (XLMR) is an inherited condition that causes failure to develop cognitive abilities, owing to mutations in a gene on the X chromosome. The latest XLMR update lists up to 136 conditions leading to 'syndromic', or 'specific', mental retardation (MRXS) and 66 entries leading to 'nonspecific' mental retardation (MRX)(1). For 9 of the 66 MRX entries, the causative gene has been identified 1. Our recent discovery of the contiguous gene deletion syndrome ATS-MR (previously known as Alport syndrome, mental retardation, midface hypoplasia, elliptocytosis, OMIM #300194), characterized by Alport syndrome (ATS) and mental retardation (MR), indicated Xq22.3 as a region containing one mental retardation gene(2,3). Comparing the extent of deletion between individuals with ATS-MR and individuals with ATS alone allowed us to define a critical region for mental retardation of approximately 380 kb, containing four genes(4-6). Here we report the identification of two point mutations, one missense and one splice-site change, in the gene FACL4 in two families with nonspecific mental retardation. Analysis of enzymatic activity in lymphoblastoid cell lines from affected individuals of both families revealed low levels compared with normal cells, indicating that both mutations are null mutations. All carrier females with either point mutations or genomic deletions in FACL4 showed a completely skewed X-inactivation, suggesting that the gene influences survival advantage. FACL4 is the first gene shown to be involved in nonspecific mental retardation and fatty-acid metabolism.
引用
收藏
页码:436 / 440
页数:5
相关论文
共 31 条
[1]   Mutational analysis of a fatty acyl-coenzyme A synthetase signature motif identifies seven amino acid residues that modulate fatty acid substrate specificity [J].
Black, PN ;
Zhang, Q ;
Weimar, JD ;
DiRusso, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) :4896-4903
[2]  
BURGEMEISTER BB, 1954, MANUAL USE COLUMBIA
[3]   Expression of fatty acid-CoA ligase 4 during development and in brain [J].
Cao, Y ;
Murphy, KJ ;
McIntyre, TM ;
Zimmerman, GA ;
Prescott, SM .
FEBS LETTERS, 2000, 467 (2-3) :263-267
[4]   Intracellular unesterified arachidonic acid signals apoptosis [J].
Cao, Y ;
Pearman, AT ;
Zimmerman, GA ;
McIntyre, TM ;
Prescott, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) :11280-11285
[5]   Cloning, expression, and chromosomal localization of human long-chain fatty acid CoA ligase 4 (FACL4) [J].
Cao, Y ;
Traer, E ;
Zimmerman, GA ;
McIntyre, TM ;
Prescott, SM .
GENOMICS, 1998, 49 (02) :327-330
[6]   XLMR genes: update 2000 [J].
Chiurazzi, P ;
Hamel, BCJ ;
Neri, G .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (02) :71-81
[7]   MECP2 is highly mutated in X-linked mental retardation [J].
Couvert, P ;
Bienvenu, T ;
Aquaviva, C ;
Poirier, K ;
Moraine, C ;
Gendrot, C ;
Verloes, A ;
Andrès, C ;
Le Fevre, AC ;
Souville, I ;
Steffann, J ;
des Portes, V ;
Ropers, HH ;
Yntema, HG ;
Fryns, JP ;
Briault, S ;
Chelly, J ;
Cherif, B .
HUMAN MOLECULAR GENETICS, 2001, 10 (09) :941-946
[8]  
des Portes V, 1999, AM J MED GENET, V85, P263, DOI 10.1002/(SICI)1096-8628(19990730)85:3<263::AID-AJMG15>3.0.CO
[9]  
2-0
[10]  
Faergeman NJ, 1997, BIOCHEM J, V323, P1